InnovaDerma PLC - Quality is more than skin deep
InnovaDerma (LON:IDP) specialises in the development, manufacture and marketing of clinically proven products in life sciences, beauty, and personal care. The company operates a portfolio of strong innovative brands, reaching customers in the UK and Australia, and increasingly in North America, Asia, and EU.
The company listed on the LSE main board in 2016 and has delivered revenue CAGR (compound annualised growth rate) of 58% and earnings per share (EPS) CAGR of 31% in its first two years (to June 2018e).
InnovaDerma reported full-year results to June 2018 on September 19. These were in line with market expectations, with 21% like-for-like revenue growth. In this report, we focus on the drivers going forward.
Quick facts: InnovaDerma PLC
Price: 60 GBX
Market Cap: £8.7 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of InnovaDerma PLC named herein, including the promotion by the Company of InnovaDerma PLC in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE
LEGAL NOTICE – IMPORTANT – PLEASE READ:
Proactive Research is a trading name of Proactive Investors Limited which is regulated and authorised by the Financial Conduct Authority (FCA) under firm registration...FOR OUR FULL DISCLAIMER CLICK HERE